| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
1 Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
2 Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
3 Plastic Surgery Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
4 Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
Correspondence: Address correspondence and reprint requests to: Jose G. Guillem, MD, MPH; E-mail: guillemj{at}mskcc.org
| ABSTRACT |
|---|
|
|
|---|
Methods: The study group consisted of 19 patients with anorectal cancer treated with external beam pelvic radiation followed by APR and RAM flap reconstruction of the perineum. A prospectively collected database was queried to identify a control group (n = 59) with anorectal cancer treated with similar radiation doses that subsequently underwent an APR without a RAM flap during the same time period. Comparison of percentages was performed with a two-sided Fishers exact test, and comparison of means was performed with Wilcoxons test.
Results: Perineal wound complications occurred in 3 (15.8%) of the RAM flap patients and 26 (44.1%) of the control patients (P = .03). The incidence of other complications was not different between groups (42.1% vs. 42.4%; P = .8). Despite an increased number of anal squamous tumors, an increased vaginectomy rate, increased use of intraoperative radiotherapy, and an increased proportion of cases with recurrent disease, the flap group had a significantly lower rate of perineal wound complications relative to the control group.
Conclusions: Perineal closure with a RAM flap significantly decreases the incidence of perineal wound complications in patients undergoing external beam pelvic radiation and APR for anorectal neoplasia. Because other complications are not increased, RAM flap closure of the perineal wound should be strongly considered in this patient population.
Key Words: Rectal cancer Perineal wound Radiotherapy Rectus abdominus myocutaneous flap
| INTRODUCTION |
|---|
|
|
|---|
One type of myocutaneous flap used for perineal wound reconstruction after rectal extirpative surgery is based on the rectus abdominis muscle.1723 The advantages of the rectus abdominus myocutaneous (RAM) flap include a wide arc of rotation based on the consistent inferior epigastric artery pedicle, large tissue bulk, consistent viability, minimal donor site morbidity, and the relative ease and speed with which the flap can be raised. In addition, the RAM flap can be used to reconstruct the vagina in sexually active women and to decrease the periurethral fibrosis and contraction associated with anorectal resection.24 The purpose of this study was to determine the effect of perineal wound closure with a RAM flap on perineal wound morbidity after preoperative combined modality therapy (CMT) and APR for anorectal cancer.
| METHODS |
|---|
|
|
|---|
The Colorectal Service database, supplemented by a comprehensive chart review, was used to determine postoperative perineal wound complications, defined as evidence of perineal wound infection, breakdown, or both. Age, sex, use of intraoperative radiotherapy, postoperative tumor stage, resection margins, location of tumor (anal vs. rectal), length of hospitalization, and incidence of complications not related to the perineal wound were determined and compared between groups.
Time to complete wound healing, as documented in the medical record by the operating surgeon, was recorded. Complete wound healing was defined as intact skin with no discharge or clinical signs of infection (erythema, tenderness, or fluctuance). Perineal wound separation was defined as skin and subcutaneous tissue breakdown with no signs of infection. A superficial perineal wound infection was defined as cellulitis with no evidence of deep tissue infection. A deep perineal wound infection was defined as infection extending deep to the subcutaneous tissue. Patients with a wound infection requiring incision and drainage or resulting in a persistent perineal sinus were categorized as deep wound infections. Perineal wounds with skin dehiscence or signs of infection were treated with standard surgical wound care techniques, including incision and drainage of collections as clinically indicated. The study was reviewed and approved by the MSKCC Institutional Review Board.
Technique of RAM Flap Construction
The RAM flap, derived from the rectus abdominus muscle, is mobilized by raising a supraumbilical skin paddle with underlying fat and rectus muscle. The right rectus muscle is preferentially chosen to allow for colostomy siting through the left rectus muscle. Perforating vessels through the anterior rectus sheath are carefully dissected to minimize the fascial resection to allow primary closure of the defect created in the anterior rectus sheath.17 The blood supply to the RAM flap is via the deep inferior epigastric artery and vein, which is mobilized as a pedicle. Flap dissection is continued to the origin of the rectus abdominus muscle on the pubis. The muscle rarely requires disinsertion to reach the pelvis. Disinsertion, if performed, should be performed with extreme care to avoid tension or twisting of the vascular pedicle.
Once fully mobilized, the flap is passed through the abdominal incision and fashioned into the perineal defect. The rectus abdominus muscle is used to fill the defect created in the pelvic floor, and the skin is used to repair the external defect. The flap is secured in place without tension by using multiple layers of sutures. The defect created in the right anterior rectus sheath is usually repaired primarily with minimal tension. The use of mesh is usually avoided because this may result in infections in a contaminated abdominal wound. In our institution, closed-suction pelvic drainage is achieved transabdominally. The basic steps of construction of a RAM flap are summarized in Fig. 1
.
|
Statistical Analysis
For categorical variables such as sex, stage, type of tumor, need for concomitant vaginectomy, margins, and various types of wound complications, equality of proportion from each category belonging either to the flap group or the control group was tested with a two-sided Fishers exact test. Equality of mean for age and time from radiation to surgery was tested with Wilcoxons test. Data were analyzed with SPluS software (Insightful Corp., Seattle, WA). A P value of
.05 was considered statistically significant.
| RESULTS |
|---|
|
|
|---|
The control group consisted of 59 patients (rectal adenocarcinoma [n = 56] and recurrent or persistent anal squamous carcinoma [n = 3]). The median time from completion of radiation to surgery was 48 days (range, 31326 days). All patients in the control group received concurrent chemotherapy (5-fluorouracil based, n = 52; irinotecan based, n = 7).
All patients received external beam radiotherapy (median dose, 5040 cGy; range, 45005940 cGy at 180 cGy/day) delivered at a single institution (MSKCC) according to previously published techniques. 25 By using 15-MV photons, a three- or four-field technique was used. The perineum was blocked as much as possible in the lateral fields.
The study and control groups were matched for demographic variables (age, postoperative tumor stage, and margin status). The mean age in the RAM flap group was 56.5 years (range, 3274 years) and in the control group was 60.3 years (range, 2580 years). The mean age was not significantly different between groups (P = .3). There were 17 women (89%) in the RAM flap group and 21 women (36%) in the control group (P < .001). There was no significant difference between the RAM flap group and the control group with regard to major comorbidities that can potentially impair wound healing (Table 1
). In addition, there was no significant difference between groups concerning the mean length of hospitalization (RAM flap group, 12.2 days; control group, 11.3 days; P = .7).
|
|
Perineal Wound Complications
There were 3 (15.8%) perineal wound complications in the RAM flap group, as compared with 26 (44.1%) in the control group (P = .03). In the RAM flap group, one patient had a superficial separation that resolved with local wound care. A second patient had wound cellulitis that responded to antibiotics. The final patient had a subcutaneous abscess that resolved after bedside incision and drainage and antibiotics. In the control group, nine patients (15.3%) had a perineal wound separation with no signs of infection, eight patients (13.5%) had a superficial perineal wound infection, and nine patients (15.3%) had a deep perineal wound infection.
The median time to perineal wound healing was 43 days (range, 15225 days) in the RAM flap group and 39.5 days (range, 151035 days) in the control group (P = .4). However, the time to perineal wound healing was substantially longer in the subgroup of patients who had a perineal wound complication compared with those did not experience a perineal wound complication. The median time to perineal wound healing in the subgroup of flap patients who experienced a perineal wound complication was 65 days (range, 53165 days). The median time to perineal wound healing in the subgroup of control patients who experienced a perineal wound complication was 92 days (range, 39 days to never healed). All patients in the RAM flap group ultimately experienced complete perineal wound healing, and 58 patients in the control group (98%) ultimately experienced complete perineal wound healing. However, one patient died of medical comorbidities 4 months after surgery, before perineal wound healing.
Other Complications
Eight (42.1%) complications were unrelated to the perineal wound in the flap group, compared with 25 (42.4%) in the control group (P = .8; Table 3
). Complications related to the abdominal wound were not significantly different between groups (study group, 10.5%; control group, 15.3%; P = .8). There were no ventral hernias in the study group (0%), compared with two in the control group (3.4%; P = 1.0). Complication data are listed in Table 4
.
|
|
| DISCUSSION |
|---|
|
|
|---|
In our study, the RAM flap group included significantly more patients with anal tumors, recurrent tumors, and need for a concomitant vaginectomy, thus suggesting that the RAM flap group required more extensive pelvic dissection and perineal resection. In addition, the radiation-to-surgery interval was longer in the RAM flap group, and this likely increased pelvic fibrosis and difficulty of dissection. However, despite this unfavorable selection bias, the incidence of perineal wound complications was decreased in the flap group.
Theoretical concerns with creation of a RAM flap include the potential for an increased incidence of complications, especially associated with the abdominal wound. A recent series examining RAM flap closure of the perineum for anal cancer in 14 patients reported no perineal wound complications but reported a 14% rate of major complications related to the abdominal incision.3 Our data suggest that there is no increase in morbidity related to the RAM flap donor site. In fact, we documented no ventral hernias, and the abdominal wound infection and small-bowel obstruction rates were not significantly different when the flap group was compared with the control group. In addition, the rate of complication unrelated to the perineal wound was not different between groups.
There have been reports of other types of myocutaneous flaps for perineal wound reconstruction. A recent report7 of 16 patients undergoing APR and intraoperative radiotherapy and perineal reconstruction with a gracilis flap showed an overall perineal complication rate of 37%. In addition, gracilis flaps have an inconsistent blood supply and a limited arc of rotation and often lack the bulk required for adequate obliteration of the pelvic dead space.7 Other studies have examined inferior gluteal myocutaneous flaps for perineal reconstruction. These flaps are associated with perineal wound complications in up to 44% of cases.8 The omental pedicle flap has also been used to obliterate the pelvic dead space associated with anorectal resection.26,27 Unfortunately, omental size and mobility are inconsistent, and although the flap is useful in the obliteration of pelvic dead space, it does not address the irradiated, poorly vascularized perineal tissue that is closely associated with perineal wound morbidity.
Several limitations of this study deserve comment. First, although well matched for age and external beam pelvic radiation dosimetry, this cohort study, which compared the study group with historical controls, has the inherent bias typical of any retrospective study. The study and control groups were significantly different in several clinical and pathologic variables. In addition, there was a wide range in the interval from radiation to surgery in the flap group. This was due to the inclusion of patients who had radiotherapy for their primary tumor and had flap reconstruction of the perineum for a recurrent tumor months to years after completion of radiation. Although the flap group was heterogeneous, the variables present in increased numbers may lead, in part, to a more complex environment for perineal wound healing. We interpret this finding as further support of the benefit of RAM flap perineal closure.
In summary, RAM flap reconstruction of the perineum after pelvic chemoradiation and surgery decreases perineal wound complications. Insofar as nonperineal wound complications and other morbidities are not increased, RAM flap closure of the perineum should be strongly considered in patients with anorectal cancer treated with preoperative CMT followed by APR. Future large prospective studies may help to better define factors associated with an increased risk of perineal wound morbidity after preoperative CMT and, thus, guide selection of patients who will likely benefit from RAM flap perineal reconstruction.
| FOOTNOTES |
|---|
Received for publication March 29, 2004. Accepted for publication September 29, 2004.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. E. Schiller, B. J. Cummings, S. Rai, L. W. Le, L. Last, P. Davey, A. Easson, A. J. Smith, and C. J. Swallow Outcomes of Salvage Surgery for Squamous Cell Carcinoma of the Anal Canal Ann. Surg. Oncol., October 1, 2007; 14(10): 2780 - 2789. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Turrini, J. Guiramand, V. Moutardier, F. Viret, D. Mokart, A. Madroszyk, B. Lelong, T. Bege, J.-L. Blache, G. Houvenaeghel, et al. Perineal Small Bowel Fistula After Pelvic Exenteration for Cancer: Technical Guidelines for Perineal Fistula Ann. Surg. Oncol., December 1, 2006; 13(12): 1622 - 1626. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |